| 1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
| Kurs | 30,46 $ | 32,69 $ | 32,14 $ | 32,14 $ | 31,25 $ | 24,62 $ |
| Änderung | 0,00% | -6,82% | -5,23% | -5,23% | -2,53% | +23,72% |
| Zeit | Titel | Quelle |
| 09.01.26 | Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly | PR Newswire |
| 09.01.26 | Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly | PR Newswire |
| 10.11.25 | Camurus reports positive topline results for CAM2056, semaglutide monthly depot | PR Newswire |
| 10.11.25 | Camurus reports positive topline results for CAM2056, semaglutide monthly depot | PR Newswire |
| 28.08.25 | Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK | PR Newswire |
| 01.07.25 | Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU | PR Newswire |
| Kaufen | Halten | Verkaufen | |
|---|---|---|---|
| Analysten | 0 | 0 | 0 |
| Markt-Lotsen | 0 | 0 | 0 |
